AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glipotec M 2mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Jantec Pharma

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glipotec M 2mg/500mg Tablet SR

Metformin/Glipizide extended-release tablets (2mg/500mg) are classified as antidiabetic medications. This dual-drug formulation treats type 2 diabetes in adults by managing blood glucose levels. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continue taking this medicine as prescribed, even with controlled blood sugar, as discontinuation without medical guidance can lead to dangerously elevated glucose levels, increasing the risk of kidney complications, vision loss, neuropathy, and limb amputation. This medication is one component of a comprehensive diabetes management plan, which must also include a doctor-recommended diet, exercise, and weight management program. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a frequent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (like sugary snacks or juice) are crucial for prevention. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain is also a potential consequence. This medicine is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring is essential, along with potential blood tests to assess blood cell counts and liver function.

Uses of Glipotec M 2mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Glipotec M 2mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Glipotec M 2mg/500mg Tablet SR. Ingest the tablet whole; do not break, crush, or chew it. Administer this medication with a meal.

Common Side effects of Glipotec M 2mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glipotec M 2mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glipotec M 2mg/500mg Tablet SR whole; do not fracture, pulverize, or chew it. Administer this extended-release tablet with a meal.

How Glipotec M 2mg/500mg Tablet SR works:

Glipotec M SR tablets (2mg/500mg) combine glimepiride and metformin, two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Glipotec M 2mg/500mg SR tablets poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glipotec M 2mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glipotec M 2mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glipotec M 2mg/500mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Glipotec M 2mg/500mg SR tablet use. Physician consultation is necessary. Routine kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Individuals with liver impairment should use Glipotec M 2mg/500mg Tablet SR cautiously, potentially requiring dose modification. Medical advice is essential. A low starting dose is typically recommended for those with mild to moderate liver disease; however, its use is contraindicated in patients exhibiting severe hepatic dysfunction.

What if you forget to take Glipotec M 2mg/500mg Tablet SR :

Should you forget a dose of your Glipotec M 2mg/500mg SR tablet, take it immediately if you remember. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Glipotec M 2mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glipotec M 2mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glipotec M 2mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but dangerous side effect is particularly risky for patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Glipotec M 2mg/500mg Tablet SR and seek immediate medical attention.
Glipotec M 2mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glipotec M 2mg/500mg SR tablets may cause common side effects including low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use can result in vitamin B12 deficiency.
Prolonged use of Glipotec M 2mg/500mg SR tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, and gait instability), urinary issues, and cognitive changes. To mitigate these risks, supplemental vitamin B12 is recommended at least annually, according to some researchers.
Glipotec M 2mg/500mg SR tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glipotec M 2mg/500mg SR tablets with alcohol is unsafe. Alcohol can worsen the drug's blood sugar-lowering effect, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Glipotec M 2mg/500mg Tabl...
58
MRP 68
14% off